Biotech spin-out secures £1.58m as bio kits sell in US

The University of Edinburgh spin-out BIOCAPTIVA has raised £1.58 million in a new funding round and launched its first product in the US.

 BIOCAPTIVA’s a novel magnetic bead technology is designed to solve one of liquid biopsy’s biggest bottlenecks: preparing blood samples for cancer research and diagnostics. By improving how cell-free DNA is captured from blood, the technology aims to make liquid biopsy testing more reliable, scalable, and accessible.

 The funding will also support R&D investment to expand BIOCAPTIVA’s product range and potential applications.

 The company is a tenant at Roslin Innovation Centre, in Midlothian Science Zone.